Monday, 13 July 2026
Clinical supply chain podcast series, Patient-centred hospital design insights, Challenging norms in mental health care
- 01
Podcast Series Explores Complexities of Clinical Supply Chains
A new six-part podcast series from Almac Clinical Services delves into the complexities of clinical trial supply chains. It covers the journey of investigational medicines from planning to distribution, highlighting the logistical challenges involved in global drug distribution. Each episode addresses different aspects, including trial kit design and supply strategy, emphasising the importance of quality and patient safety. This series aims to provide insights into the operational intricacies that impact clinical trial execution.
via BioPharma Dive
- 02
Hospital Architecture and Patient-Centered Design Discussed
Maggie Keswick Jencks, in 1994, critiqued hospital architecture for its negative impact on patient perception, suggesting that environments often convey a message of unimportance to patients. She advocated for a shift towards designs that welcome and reassure patients, enhancing their treatment experience. This perspective underscores the potential for architectural changes to improve patient outcomes and satisfaction in clinical settings.
via The Lancet
- 03
New Perspective on Mental Health Care Challenges Psychiatry's Norms
Khameer Kidia's book, Empire of Madness, contributes to the ongoing debate regarding the scope and moral responsibilities of psychiatry. It critiques the dominance of biomedical approaches and highlights the importance of structural and social determinants in mental health. The work resonates with existing discussions in global mental health, addressing the historical connections between psychiatry and power dynamics. This perspective is particularly relevant for those involved in mental health care.
via The Lancet
- 04
Concerns Raised Over Long-term Hip Replacement Outcomes
A systematic review and meta-analysis by Veronica Pentland and colleagues examined over 1.9 million total hip arthroplasties, utilising data from 29 clinical studies and eight national joint registries. The study provides valuable insights into the long-term outcomes of hip replacements, with registry data spanning more than 20 years. However, the authors express concerns regarding the extrapolation of data to predict 25 and 30-year survivorship rates, specifically questioning the reliability of the reported 92.1% survivorship estimate at 30 years.
via The Lancet · also covered by The Lancet, The Lancet
- 05
Search for New Global Fund Executive Director Intensifies
The Global Fund is seeking a successor to Peter Sands as Executive Director amid impending funding cuts from traditional donors. This leadership change is crucial as it will influence the organisation's direction and ability to support global health initiatives. The outcome of this search may have significant implications for public health policy, including in Australia.
via The Lancet
- 06
World Arthroplasty Study Responds to Comments on Hip Replacement Outcomes
The World Arthroplasty Study Participants Collaboration has expressed gratitude to Yosef Sourougeon and colleagues, Peter G Delaney and Nicholas S Piuzzi, and Kaj S Emanuel and colleagues for their constructive feedback on a recent article regarding long-term outcomes of total hip replacement. The collaboration welcomes the comments and is pleased to provide clarifications. This response highlights ongoing discussions in the field of arthroplasty and the importance of collaborative feedback in clinical research.
via The Lancet
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.